These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 24000503

  • 21. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
    Wilkinson MJ, Fitzgerald JE, Strauss DC, Hayes AJ, Thomas JM, Messiou C, Fisher C, Benson C, Tekkis PP, Judson I.
    Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743
    [Abstract] [Full Text] [Related]

  • 22. Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
    Kang YK, Kang BW, Im SA, Lee JL, Park SR, Kang WK, Chang HM, Kim TW, Oh DY, Jung KH, Ryu MH.
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):43-51. PubMed ID: 23053257
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
    Li J, Dang YZ, Gao J, Shen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
    [Abstract] [Full Text] [Related]

  • 26. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
    Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC.
    J Clin Oncol; 2008 Feb 01; 26(4):626-32. PubMed ID: 18235122
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
    Láng I, Hitre E.
    Orv Hetil; 2005 May 01; 146(18 Suppl 1):935-41. PubMed ID: 15921308
    [Abstract] [Full Text] [Related]

  • 29. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour.
    Machlenkin S, Pinsk I, Tulchinsky H, Ziv Y, Sayfan J, Duek D, Rabau M, Walfisch S.
    Colorectal Dis; 2011 Oct 01; 13(10):1110-5. PubMed ID: 21040362
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
    Haugland HK, Jebsen NL, Mannelqvist M, Skar R, Eide J, Øvrebø K, Horn A, Jensen DK, Monge OR, Lilleng PK.
    Tidsskr Nor Laegeforen; 2005 Apr 07; 125(7):868-72. PubMed ID: 15815732
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A multicenter long-term study of imatinib treatment for Japanese patients with unresectable or recurrent gastrointestinal stromal tumors.
    Ogata K, Mochiki E, Ojima H, Haga N, Fukuchi M, Aihara R, Ando H, Uchida N, Toyomasu Y, Suzuki M, Kimura A, Kogure N, Yokobori T, Ohno T, Kuwano H.
    J Surg Oncol; 2014 Dec 07; 110(8):942-6. PubMed ID: 25164620
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
    Haller F, Detken S, Schulten HJ, Happel N, Gunawan B, Kuhlgatz J, Füzesi L.
    Ann Surg Oncol; 2007 Feb 07; 14(2):526-32. PubMed ID: 17139461
    [Abstract] [Full Text] [Related]

  • 38. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
    Zhu J, Wang Y, Hou M, Li HY, Zhang J.
    Oncology; 2007 Feb 07; 73(5-6):324-7. PubMed ID: 18497504
    [Abstract] [Full Text] [Related]

  • 39. Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.
    Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, Adenis A, Rios M, Cupissol D, Pérol D, Blay JY, Le Cesne A.
    BMC Cancer; 2011 Feb 15; 11():72. PubMed ID: 21324142
    [Abstract] [Full Text] [Related]

  • 40. [Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
    Heger U, Weitz J, Lordick F.
    Chirurg; 2008 Jul 15; 79(7):630-7. PubMed ID: 18548219
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.